Importance of Measuring Glycosylated Hemoglobin in Patients With Myocardial Infarction and Known Diabetes Mellitus

American Journal of Cardiology

Volumn 105, Issue 8, 2010, Pages 1090-1094

  Stolker, Joshua M ^a,b   Sun, Dazhong ^a,b   Conaway, Darcy G ^b   Jones, Philip G ^a   Masoudi, Frederick A ^c,d   Peterson, Pamela N ^c   Krumholz, Harlan M ^e   Kosiborod, Mikhail ^a,b   Spertus, John A ^a,b  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d DENVER HEALTH MEDICAL CENTER   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC DIET; DISEASE SEVERITY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE QUALITY; HEALTH INSURANCE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OBSERVATIONAL STUDY; PATIENT CARE; PATIENT COUNSELING; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT PLANNING; UNITED STATES; WEIGHT REDUCTION;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 77950368566     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.12.010     Document Type: Article

References (29)

1. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
2. Morocutti G., and The BARI Investigators. Bypass treatment is better than angioplasty in reducing long-term mortality in diabetic patients with multivessel coronary disease [article in Italian]. Ital Heart J 1 suppl (2000) 951-952
3. Schwartz L., Kip K.E., Frye R.L., Alderman E.L., Schaff H.V., and Detre K.M. Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 106 (2002) 2652-2658
4. Berger P.B., Velianou J.L., Aslanidou Vlachos H., Feit F., Jacobs A.K., Faxon D.P., Attubato M., Keller N., Stadius M.L., Weiner B.H., Williams D.O., and Detre K.M. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 38 (2001) 1440-1449
5. Donahoe S.M., Stewart G.C., McCabe C.H., Mohanavelu S., Murphy S.A., Cannon C.P., and Antman E.M. Diabetes and mortality following acute coronary syndromes. JAMA 298 (2007) 765-775
6. Malmberg K., Ryden L., Efendic S., Herlitz J., Nicol P., Waldenstrom A., Wedel H., and Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
7. Malmberg K., Ryden L., Wedel H., Birkeland K., Bootsma A., Dickstein K., Efendic S., Fisher M., Hamsten A., Herlitz J., Hildebrandt P., MacLeod K., Laakso M., Torp-Pedersen C., and Waldenstrom A. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
8. Standards of medical care in diabetes-2008. Diabetes Care 31 suppl (2008) S12-S54
9. Skyler J.S., Bergenstal R., Bonow R.O., Buse J., Deedwania P., Gale E.A., Howard B.V., Kirkman M.S., Kosiborod M., Reaven P., and Sherwin R.S. Intensive Glycemic Control and the Prevention of Cardiovascular Events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation 119 (2009) 351-357
10. Werner R.M., Greenfield S., Fung C., and Turner B.J. Measuring quality of care in patients with multiple clinical conditions: summary of a conference conducted by the Society of General Internal Medicine. J Gen Intern Med 22 (2007) 1206-1211
11. Spertus J.A., Peterson E., Rumsfeld J.S., Jones P.G., Decker C., and Krumholz H. The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)-evaluating the impact of myocardial infarction on patient outcomes. Am Heart J 151 (2006) 589-597
12. Standards of medical care in diabetes. Diabetes Care 28 suppl (2005) S4-S36
13. Gerstein H.C. Glycosylated hemoglobin: finally ready for prime time as a cardiovascular risk factor. Ann Intern Med 141 (2004) 475-476
14. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
15. Kosiborod M., Rathore S.S., Inzucchi S.E., Masoudi F.A., Wang Y., Havranek E.P., and Krumholz H.M. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
16. Stranders I., Diamant M., van Gelder R.E., Spruijt H.J., Twisk J.W., Heine R.J., and Visser F.C. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164 (2004) 982-988
17. van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., and Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
18. Saydah S.H., Fradkin J., and Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291 (2004) 335-342
19. Gerstein H.C., Miller M.E., Byington R.P., Goff Jr. D.C., Bigger J.T., Buse J.B., Cushman W.C., Genuth S., Ismail-Beigi F., Grimm Jr. R.H., Probstfield J.L., Simons-Morton D.G., and Friedewald W.T. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559
20. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., Marre M., Cooper M., Glasziou P., Grobbee D., Hamet P., Harrap S., Heller S., Liu L., Mancia G., Mogensen C.E., Pan C., Poulter N., Rodgers A., Williams B., Bompoint S., de Galan B.E., Joshi R., and Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 (2008) 2560-2572
21. Nathan D.M., Cleary P.A., Backlund J.Y., Genuth S.M., Lachin J.M., Orchard T.J., Raskin P., and Zinman B. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005) 2643-2653
22. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 (1998) 854-865
23. Fonarow G.C. In-hospital initiation of statin therapy in acute coronary syndromes: maximizing the early and long-term benefits. Chest 128 (2005) 3641-3651
24. Fonarow G.C. Practical considerations of beta-blockade in the management of the post-myocardial infarction patient. Am Heart J 149 (2005) 984-993
25. Fonarow G.C. When to initiate beta-blockers in heart failure: is it ever too early?. Curr Heart Fail Rep 2 (2005) 94-99
26. Fonarow G.C., Wright R.S., Spencer F.A., Fredrick P.D., Dong W., Every N., and French W.J. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 96 (2005) 611-616
27. Phillips L.S., Branch W.T., Cook C.B., Doyle J.P., El-Kebbi I.M., Gallina D.L., Miller C.D., Ziemer D.C., and Barnes C.S. Clinical inertia. Ann Intern Med 135 (2001) 825-834
28. Conaway D.G., O'Keefe J.H., Reid K.J., and Spertus J. Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome. Am J Cardiol 96 (2005) 363-365
29. Norhammar A., Tenerz A., Nilsson G., Hamsten A., Efendic S., Ryden L., and Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359 (2002) 2140-2144